My Personal Therapeutics Ltd. (trading as Vivan Therapeutics), a global leader in personalised cancer therapeutics and in-vivo high throughput drug screening, announced the addition of Lilly Wollman to its board of directors. Lilly Wollman is a seasoned team-builder and entrepreneurial leader with a 20-year track record in finance and investing. Currently, she is pursuing an…